Company Overview and News

 
Pacific for Gwalia power job

2018-10-11 businessnews.com.au
Pacific Energy has been awarded a contract to install additional generation capacity at St Barbara's Gwalia gold mine as part of an expansion project.
PEA SBM

 
Gas expansion for Pacific at Gwalia

2018-10-11 businessnews.com.au
Pacific Energy has been awarded a variation to an ongoing power contract with St Barbara at the Gwalia gold mine, with the Gnangara-based business to expand generation capacity by 6 megawatts to be 20.7MW.
PEA SBM

 
Pacific Energy Limited increases annual revenue to $68.1 million

2018-08-24 proactiveinvestors.com.au
Pacific Energy Limited (ASX:PEA) has increased its annual revenues by $4.9 million or 19% to $68.1 million.
PEA

 
MinRes adds to $30m Wodgina power contract

2018-08-22 australianmining.com.au
Contract Power’s agreement with Mineral Resources at the Wodgina lithium project has been updated, resulting in the addition of 17MW of temporary power and increasing the value of the contract to $30 million.
PEA MALRY MALRF MIN

 
MinRes adds $30m to Wodgina power contract

2018-08-22 australianmining.com.au
Contract Power’s agreement with Mineral Resources at the Wodgina lithium project has been updated, resulting in the addition of 17MW of temporary power and an extra $30 million in value.
PEA MALRY MALRF MIN

 
Pacific extends MinRes contract to $30m

2018-08-21 businessnews.com.au
Pacific Energy has added a 17-megawatt power station to its recent contract at Mineral Resources' Wodgina lithium project, taking the total contract value to $30 million.
PEA MALRY MALRF MIN

 
Pacific flags $15m impairments

2018-07-02 businessnews.com.au
Pacific Energy says it will meet its underlying earnings guidance for the 2018 financial year, but has flagged impairments totalling $14.8 million.
PEA

 
Pacific Energy finds smooth M&A path

2018-04-09 businessnews.com.au
for unrestricted access to all Business News content including BNiQ, Daily Business Alerts & the fortnightly print publication.
PEA

3
Pacific Energy acquires Contract Power for $90m

2018-03-25 australianmining.com.au
Pacific Energy has secured an agreement to buy Contract Power Group, which has a worth of $90 million.
40F PLS PILBF GXY GALXF TAW PEA TWNAF

 
Pacific Energy in $90m acquisition

2018-03-23 businessnews.com.au
Pacific Energy has strengthened its position in the remote power market by striking a deal to acquired Kewdale-based Contract Power Group for $90 million in cash and shares, adding to its existing operations through subsidiary Kalgoorlie Power Systems.
PEA

 
Pacific in $90m power buy

2018-03-23 businessnews.com.au
Pacific Energy has acquired Kewdale-based Contract Power Group for $90 million in a cash and scrip deal, adding to the company’s primary asset Kalgoorlie Power Systems.
PEA

 
Mark my words podcast

2018-03-23 businessnews.com.au
In this Business News podcast Mark Beyer and Mark Pownall discuss Trump’s trade war WA impact, residential property prices, population and labour statistics, World Trade Centre, Pacific Energy, ride sharing and our special report Most Influential.
PEA

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to ASX:PEA / PACIFIC ENERGY LIMITED on message board site Silicon Investor.

Peak Oil reality or Myth, of an out of Control System Peak Oil reality or Myth, of an out of Control System Peak Oil reality or Myth, of an out of Control System Chesapeake Gold Chesapeake Gold Chesapeake Gold
Chesapeake Gold (CKG.V) Chesapeake Gold (CKG.V) Chesapeake Gold (CKG.V) Happy Birthday, Peach Happy Birthday, Peach Happy Birthday, Peach
Chesapeake Energy CHK Chesapeake Energy CHK Chesapeake Energy CHK Peace! Peace! Peace!
PEAK OIL - The New Y2K or The Beginning of the Real End? PEAK OIL - The New Y2K or The Beginning of the Real End? PEAK OIL - The New Y2K or The Beginning of the Real End? PEACE PEACE PEACE
Winspear Diaminds (Bulls Board) Winspear Diaminds (Bulls Board) Winspear Diaminds (Bulls Board) Peak Oil - Not If but When Peak Oil - Not If but When Peak Oil - Not If but When